Introduction
Coronary artery disease is one of the most important health problems in both developed and developing countries [1] . Coronary artery disease may be in a wide range of stable angina pectoris and acute coronary syndrome including USAP (unstable angina pectoris), non-STEMI (non-ST elevation myocardial infarction) and STEMI (ST elevation myocardial infarction) and their prognosis and course vary widely [2] . Acute coronary syndromes are an important cause of hospitalization, mortality and morbidity worldwide [3] . Destruction and rupture of a stable plaque is also a stimulant for thrombogenesis and triggers a loss of function in the myocardial area of the coronary artery, whose flow is impaired in the acute coronary EXPERIMENTAL BIOMEDICAL RESEARCH http://www.experimentalbiomedicalresearch.com syndrome, as well as the loss of cell death, ischemia-induced arrhythmias, and sudden cardiac death [4] . The importance and place of platelets and other hematological parameters in both acute and stable coronary artery diseases have been shown in many studies [5] . When the relationship between the activity and size of platelets is examined, it is known that thrombogenic activity of platelets increases in their size to the increase of thrombogenic granules on the platelets and of the receptors on the surface [6] . PDW (platelet distribution width), PPR (PDW to platelet ratio), MPV (mean platelet volume), MPR (MPV to platelet ratio) values are parameters that show the size and activity of platelets [7, 8, 9] . These parameters, which are indirect indicators of platelet activation, have been studied in a wide variety of disease groups such as cancer, inflammatory diseases, rheumatologic diseases, hypertension, diabetes, dyslipidemia and obesity and the effects of them on the diagnosis, follow-up and prognosis of diseases were shown in the literature [10, 11] . The aim of our study is to compare the platelet volume indices using PDW, PPR, MPV and MPR values in patients with acute coronary syndrome. The criteria for ST segment elevation were taken as follows: 1) At least 1 mm ST segment elevation in at least two successive leads, 2) 2.5 mm in men under 40 years of age, 2 mm in men over 40 years and 1.5 mm ST segment elevation in women in V2 and V3, 3) 0.5 mm ST segment elevation in V7-V9 (at least 2 consecutive lines), 4) 0.5 mm ST segment elevation in V3R and V4R (1 mm in men under 40). Coronary angiography was performed by femoral or radial route using Seldinger technique. Coronary angiograms were evaluated by at least two cardiologists who were experienced and blinded to the independent study. Venous blood samples were taken within the first 6 h of admission to hospital. Glucose, creatinine and lipid profiles were determined by standard methods. MPV and PDW values were studied in tri-potassium EDTA (Ethylenediaminetetraacetic acid) tubes. The PPR was calculated by dividing the PDW value by the number of platelets and MPR was calculated by dividing the MPV value by the number of platelets. Patients who were diagnosed with acute coronary syndrome in the last 6 months, patients with coronary bypass history, decompensated heart failure, atrial fibrillation, cardiomyopathy or congenital heart disease, inflammatory disease, renal or hepatic failure, cancer, septicemia, pregnancy and thrombocytopenia were excluded from the study. The study was approved by the Local Ethics Committee of Bolu Abant Izzet Baysal University Hospital, Turkey. While the use of acetylsalicylate, clopidogrel, statin, calcium channel blocker and ACE (angiotensin-converting enzyme) inhibitor were not significantly different between groups; ARB (angiotensin receptor blocker) and beta-blockers were found to be the lowest in the STEMI group and the highest in the non-STEMI group (p=0.008 and p=0.001) ( Table  1) . When blood parameters of patients were examined, no significant difference was found between creatinine, LDL-cholesterol, HDLcholesterol, triglyceride, total cholesterol, hematocrit, hemoglobin and platelet counts while plasma glucose levels were highest in the USAP group; lowest in the STEMI group (p = 0.02). There was no statistically significant difference between the three groups in terms of platelet function tests which formed the aim of our study, PDW (p=0.26), PPR (p=0.87), MPV (p=0.41) and MPR (p=0.78) ( Table 2 ).
Methods

Statistical analysis
Discussion
In this study, platelet volume indices PDW, PPR, MPV and MPR values were not significantly different among the patients with acute coronary syndrome. Atherosclerosis causing coronary artery disease (CAD) is a chronic process. After a silent period, a stable or unstable clinical picture may occur. Acute coronary syndrome (ACS) is a wide spectrum of exacerbation periods, including USAP, non-STEMI and STEMI. Inflammation and platelet activation are the cornerstones of both atherosclerosis and acute coronary syndromes. Platelets are important triggers in the atherothrombotic process with their direct inflammatory mediators as well as their direct effects on the inflammatory pathway [13] . Activated platelets initiate the free arachidonic acid pathway; prostaglandins produced in the process starting with this pathway, especially thromboxane A2 is the most potent vasoconstrictor and platelet activating substrate [14] . Large platelets are more enzymatic and metabolically more active due to the higher content of pro-aggregate mediators and more surface proteins (pselectin, Glycoprotein -IIb/IIIa) [15, 16] . The two most well-known parameters showing the platelet size are MPV and PDW, and these two values have been used in the literature for many times [7, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . PDW is more specific in demonstrating activation; unlike MPV, it does not increase with simple platelet swelling [17] .
An example might be the correlation between increased PDW and MPV with shortened bleeding time [18] . In addition to studying the prognostic significance of these markers in a wide variety of patient groups, patients with acute coronary syndrome were compared with stable coronary artery disease and non-cardiac patients [2] . The comparison between the 3 groups was not found in the existing literature and such a comparison of these values especially in the Turkish population constitutes a first study. In the literature, platelet volume, PDW and P-LCR (platelet larger cell ratio) values were significantly higher in USAP and acute MI patients than in stable CAD and control group [19] . While these values were used for prognosis as well, PDW value was determined as a predictor in the patients who had saphenous vein occlusion [20] . In another study, STEMI patients were compared with the control group and as a result, PDW and MPV values were found to be significantly high and were associated with STEMI severity [7] . Following the literature there are studies in parallel with the results of our study, in which no significant relationship was observed. For example, in 1300 patients who underwent percutaneous coronary intervention, in the study that investigated the relationship between peri-procedural MI and PDW, patients were examined in 3 groups according to PDW value and it was concluded that the increase in PDW did not increase the risk of periprocedural MI [21] . In another study, 2330 patients who underwent coronary angiography were divided into 3 groups. There was no significant relationship between CAD grade and carotid IMT (intima-media thickness), MPV and PDW [18] . Similar findings were also found in the studies of Tavil et al and Halbmayer et al [22] [23] [24] . In the literature, the relation of MPR and PPR ratios of platelet volume indices with prognosis in various cancer types have been studied [25] . The correlation with the severity of coronary artery disease in patients with non-STEMI [26] and the relationship with disease severity in pediatric intensive care unit (PICU) [27] have been studied previously. However, in our study, these values were compared in 3 types of acute coronary syndromes. In our study, we examined patients in 3 groups under the title of acute coronary syndrome and compared them with platelet volume index parameters, however we did not find any significant difference. Although these 3 clinical manifestations may present with different clinical and severity, the underlying pathophysiological events may overlap in a common pathway. In addition, circulating platelets have a life span of about 10 days [28] . Since, the blood samples were taken from the patients who were in the first 6 h of hospitalization, our calculation included the 90% of the platelets which are in fact independent of the acute coronary syndrome but already in the circulation at the time of measurement. Thus, this may explain the statistical insignificance between the groups. Although previous studies have shown that these values change with blood uptake in supine or sitting position [29] , patients' positions during blood collection could not be standardized due to the retrospective design of our study. This deficiency may have affected statistical values. The fact that the study was conducted only in the Turkish population may prevent us to generalize the values that have been shown to be influenced by ethnic factors [30] . Single-center and the limited number of patients might be considered as the other limitations in our study. 
